(Q48965780)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21813307%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

Spinal cord compression in young children with type VI mucopolysaccharidosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21813307%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21813307%20AND%20SRC:MED&resulttype=core&format=json

Dafne Dain Gandelman Horovitz

9 February 2020

1

object named as

Dafne Dain Gandelman Horovitz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21813307%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Tatiana de Sá Pacheco Carneiro Magalhães

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21813307%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Alessandra Pena e Costa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21813307%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Luis Eduardo Carelli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21813307%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Daniel Souza e Silva

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21813307%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Anna Patricia Freitas de Linhares e Riello

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21813307%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

23 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21813307%20AND%20SRC:MED&resulttype=core&format=json

Molecular Genetics and Metabolism

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21813307%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21813307%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21813307%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

295-300

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21813307%20AND%20SRC:MED&resulttype=core&format=json

The mucopolysaccharidoses: a success of molecular medicine.

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.019

Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.019

The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.019

A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.019

Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.019

Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-ac

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.019

Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, o

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.019

Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.019

Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.019

Intrathecal administration of recombinant human N-acetylgalactosamine 4-sulfatase to a MPS VI patient with pachymeningitis cervicalis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.019

Cervical myelopathy due to dural compression in mucopolysaccharidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.019

Neurosurgical interventions in children with Maroteaux-Lamy syndrome. Case report and review of the literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.019

Cervical cord compression in mucopolysaccharidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.019

Management guidelines for mucopolysaccharidosis VI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.019

Multilevel myelopathy in Maroteaux-Lamy syndrome and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.019

Myelopathy associated with Maroteaux-Lamy syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.019

Compressive myelopathy associated with type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.019

Myelopathy due to diffuse thickening of the cervical dura mater in Maroteaux-Lamy syndrome: report of a case

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.019

The contribution of magnetic stimulation of the motor cortex to the diagnosis of cervical spondylotic myelopathy. Correlation of central motor conduction to distal and proximal upper limb muscles with clinical and MRI findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.019

Magnetic stimulation of the motor cortex in cervical spondylosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.019

Electrical stimulation of the motor tracts in cervical spondylosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.019

Abnormal somatosensory evoked potentials indicate compressive cervical myelopathy in mucopolysaccharidoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.019

Spinal cord compression in Morquio-Brailsford's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.019

Craniovertebral instability with spinal cord compression in a 17-month-old boy with Sly syndrome (mucopolysaccharidosis type VII): a surgical dilemma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.019

Congenital osseous anomalies of the upper and lower cervical spine in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.07.019

10.1016/J.YMGME.2011.07.019

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21813307%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference